No Data
No Data
GLONGHUI ANNOUNCEMENT SELECTION (HK Stock) | BeiGene (06160.HK) Product Revenue Increased by 82% in the First Quarter, R&D Expenses Reached US$460 Million and Ranked Among the Top 15 Global Oncology Treatment Innovators
[Today's Focus] BeiGene (06160.HK)'s product revenue increased 82% in the first quarter, and R&D expenses reached US$460 million, and R&D expenses reached US$460 million. BeiGene (06160.HK) announced that in the first quarter of 2024, the company's total revenue reached US$752 million, of which product revenue reached US$747 million, an increase of 82% over the previous year. Baiyuezer's global sales reached US$489 million, thanks to sales growth of 153% and 243% year-on-year in the US and Europe, respectively; with the recent approval of the FDA for the fifth indication, Baiyuezer has now become
China High Precision (00591.HK) stock price fluctuates abnormally and there have been no major changes in business operations and financial conditions
Gelonghui, May 8, 丨 China High Precision (00591.HK) announced that the company's board of directors noticed unusual fluctuations in the stock price and trading volume of the company's shares recently. After making all reasonable inquiries about the company in the relevant circumstances, the Board confirmed that it was unaware of any reason for the share price or trading volume fluctuations, or any information that must be published to avoid false markets in the company's securities, or any insider information required to be disclosed under Part XIVA of the Securities and Futures Ordinance, Chapter 571 of the Laws of Hong Kong. The Company also confirmed that there have been no significant changes in the business operations and financial situation of the Company and its subsidiaries.
C HIGHPRECISION: INTERIM REPORT 2023/2024
China High Precision (00591) announced interim results. Shareholders' share loss of 5.68 million yuan increased by 84% year-on-year
China High Precision (00591) announced interim results for the six months ended December 31, 2023. Group revenue holders...
C HIGHPRECISION: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 31 DECEMBER 2023
China High Precision (00591.HK) held a board meeting on February 29 to review and approve the interim results
Gelonghui, Feb. 15, 丨 China High Precision (00591.HK) announced that it will hold a board meeting at 4:00 p.m. on February 29, 2024 (Thursday) to review and approve the unaudited interim results of the company and its subsidiaries for the six months ended December 31, 2023 for publication and consideration of the payment of an interim dividend (if any).
No Data